Buprenorphine Hydrochloride

Spezifikationen

53152-21-9CAS-Nummer

258-396-8EG-Nummer

(1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol;hydrochlorideIUPAC-Name

C29H42ClNO4Chemische Formel

504.1 g/molMolekulargewicht

BUPRENORPHINE HYDROCHLORIDE; 53152-21-9; Finibron; Belbuca; Buprenorphine Hcl; Buprex; Vetergesic; Anorfin; Buprederm; Lepetan; Nopan; UM 952; Probuphine; RX 6029-M HCl; 56W8MW3EN1; DTXSID2048905; NIH8805; CL 112,302; NIH 8805; NIH-8805; CL-112302; Buprenorphine hydrochloride ciii; RX6029-M HCL; RX-6029-M HCL; CHEBI:652822; M-6029; SCH-028444; BUNAVAIL COMPONENT BUPRENORPHINE HYDROCHLORIDE; (5alpha,7alpha(S))-alpha-tert-Butyl-17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinan-7-methanol hydrochloride; DTXCID9028831; Espranor; Prefibin; Simbadol; Natzon; Gabup; Ethiqa XR; Buprenorphine Sublingual; RefChem:56706; BUPRENORPHINE HCL SL; Hydrochloride, Buprenorphine; Buprenorphine Sublingual C-III; Buprenorphine Hydrochloride Sublingual; (2S)-2-((5R,6R,7R,14S)-17-(Cyclopropylmethyl)-4,5-epoxy-3-hydroxy-6-methoxy-6,14-ethanomorphinan-7-yl)-3,3-dimethylbutan-2-ol monohydrochloride; 258-396-8; Subutex; Buprenex; Buprenorphine.HCl; 21-Cyclopropyl-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine hydrochloride; UNII-56W8MW3EN1; Norspan; UM-952; BEMA-buprenorphine; MR 56; Buprenorphine Depot; Buprenex (TN); 21-cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine hydrochloride; 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, hydrochloride, (5alpha,7alpha(S))-; 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, hydrochloride, [5alpha,7alpha(S)]-; EINECS 258-396-8; BEMA LA; CL 112302; Buprenorphine hydrochloride [USAN:USP:JAN]; BEMA long acting analgesic; Epitope ID:2270795; Buprenorphine (hydrochloride); TSN-09; SCHEMBL17220698; ETI-311; UAIXRPCCYXNJMQ-RZIPZOSSSA-N; FTB-8127; HY-B0701; RX 6029-M; IX-1003; IX-1004; IX-1005; Buprenorphine hydrochloride (JP17/USP); BUPRENORPHINE HYDROCHLORIDE [MI]; BUPRENORPHINE HYDROCHLORIDE [JAN]; Buprenorphine hydrochloride CRS - * psy; BUPRENORPHINE HYDROCHLORIDE [USAN]; Buprenorphine hydrochloride[ORANGE BOOK]; CL112302; BUPRENORPHINE HYDROCHLORIDE [MART.]; BUPRENORPHINE HYDROCHLORIDE [VANDF]; BUPRENORPHINE HYDROCHLORIDE [USP-RS]; BUPRENORPHINE HYDROCHLORIDE [WHO-DD]; D00836; V-1003; V-1004; V-1005; BUPRENORPHINE HYDROCHLORIDE [EP IMPURITY]; BUPRENORPHINE HYDROCHLORIDE [EP MONOGRAPH]; BUPRENORPHINE HYDROCHLORIDE [USP IMPURITY]; BUPRENORPHINE HYDROCHLORIDE [USP MONOGRAPH]; SUBOXONE COMPONENT BUPRENORPHINE HYDROCHLORIDE; Buprenorphine.HCl, 1mg/ml in Methanol (as free base); Q27105186; Buprenorphine hydrochloride, British Pharmacopoeia (BP) Reference Standard; Buprenorphine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; Buprenorphine hydrochloride, United States Pharmacopeia (USP) Reference Standard; (18R)-17-(Cyclopropylmethyl)-18-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-6-methoxy-5alpha,6beta,14beta-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol--hydrogen chloride (1/1); 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, hydrochloride (1:1), (alphaS,5alpha,7alpha)-Synonyme